INKEF Capital is an Amsterdam-based venture capital firm that invests in early-stage technology and healthcare companies across Europe. The firm takes a long-term, hands-on approach to building companies, with a 20-year fund life that allows it to be a patient partner.
Deal activity increased 400% year-over-year (5 deals in the last 12 months). Their most common stage is series-a (44% of deals). Average disclosed round size is $47.5M (across 35 rounds with reported amounts).
Portfolio
46
Fund Size
—
Top Stage
Series A
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
84 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix | Series B | — | Aug 2026 |
 TargED Biopharmaceuticals B.V. | Unknown | — | Jun 2026 |
 Quantum Motion | Series B | — | May 2026 |
 Silverflow | Series B | $40M | Mar 2026 |
 Quantum Motion | Series C | $160M | Jan 2026 |
| TargED Biopharmaceuticals B.V. | Series A | — | Dec 2025 |
 Salvia BioElectronics | Series B | $60M | May 2025 |
 iOnctura | Series B | — | Jun 2024 |
| Silverflow | Unknown | — | Nov 2023 |
 NMD Pharma | Series B | — | Nov 2023 |
 Anavo Therapeutics | Seed | — | May 2023 |
| AAnavo | Seed | — | May 2023 |
| Quantum Motion | Growth | $51M | Feb 2023 |
| Quantum Motion | Series C | $50.5M | Feb 2023 |
| Quantum Motion | Series B | $42M | Jan 2023 |
 Happeo | Series B | $26M | Jul 2022 |
 Baserow | Seed | $5.2M | Jul 2022 |
| PPrecirix | Series B | — | Mar 2022 |
 ChannelEngine | Growth | $50M | Mar 2022 |
 Scenic Biotech BV | Series A | $31M | Mar 2022 |
| TargED Biopharmaceuticals B.V. | Series A | — | Feb 2022 |
| NMD Pharma | Unknown | — | Feb 2022 |
| TTarged Biopharmaceuticals | Series A | — | Jan 2022 |
 Tessa | Series A | $200M | Jan 2022 |
| PPrecirix | Seed | — | Jan 2022 |
Page 1 of 4
Top Co-Investors
M Ventures10 shared
Novo Holdings A/S9 shared
Mission BioCapital9 shared
Oxford Science Enterprises8 shared
Parkwalk Advisors7 shared
EQT Life Sciences7 shared
Gilde Healthcare7 shared
Novo Capital7 shared
Porsche Automobil Holding SE6 shared
BioGeneration Ventures6 shared
Fund+6 shared
Hadean Ventures6 shared
Jeito Capital6 shared
MRL Ventures Fund6 shared
Octopus Ventures5 shared
British Patient Capital5 shared
British Business Bank5 shared
Sunstone Life Science Ventures5 shared
Gimv5 shared
Last updated: 20 October 2026